期刊文献+

氨茶碱联合参麦注射液治疗慢性阻塞性肺疾病的临床研究 被引量:4

Clinical study on the Aminophylline combined with Shenmai Injection in the treatment of chronic obstructive pumlonary diseases
下载PDF
导出
摘要 目的探讨氨茶碱联合参麦注射液治疗慢性阻塞性肺疾病的临床应用价。方法选取本院呼吸内科的慢性阻塞性肺疾病(COPD)患者80例,将其分为治疗组和对照组,每组各40例。对照组给予氨茶碱治疗,治疗组在对照组治疗基础上给予参麦注射液治疗。观察对比两组临床疗效、肺功能指标和动脉血压分析的变化。结果治疗组总有效率为92.5%,对照组总有效率为82.5%,两组总有效率比较,差异有统计学意义(P<0.05)。治疗后治疗组肺功能和动脉血气分析情况优于对照组,差异有统计学意义(均P<0.05)。结论氨茶碱联合参麦注射液治疗慢性阻塞性肺疾病较单纯的西医治疗效果好,值得临床推广应用。 Objective To discuss the clinical study on the Aminophylline combined with Shenmai Injection in the treat- ment of chronic obstructive pumlonary diseases (COPD). Methods Eighty patients with chronic obstructive pumlonary dis- eases were selected and divided into treatment group and control group in our hospital, each group had 40 cases. The pa- tients in the control group were given Aminophylline. The patients in the treatment group were given Shenmai Injection based on the treatment of control grougp. The clinical effect, lung function and arterial blood gas analysis of two groups were obversed and analysed. Results The total effect rate of treatment group was 92.5%, and 82.5% in the control group, there was significant difference between two groups (P 〈 0.05). Lung function and arterial blood gas analysis of treatment group were better than those of control group after treatment, there were significant differences between two groups (all P 〈 0.05). Conclusion Aminophylline combined with Shenmai Injection in the treatment of chronic obstructive pumlonary dis- eases has a better effect than the Western medicine treatment, so it is worthy to use in clinic.
出处 《中国当代医药》 2012年第25期36-37,共2页 China Modern Medicine
关键词 氨茶碱 参麦注射液 慢性阻塞性肺疾病 疗效 Aminophylline Shenmai Injection Chronic obstructive pumlonary diseases Curative effect
  • 相关文献

参考文献6

二级参考文献37

共引文献62

同被引文献39

引证文献4

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部